治疗发作,偏头痛和双极性疾病的氨酸疗法的进展
概括
和双相情感障碍的药物瓦尔酸盐显示出新用途的前景. 本综述涵盖了氨酸 (VPA) 的扩展应用,副作用以及未来的研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 瓦尔酸是治疗,情绪障碍和偏头痛的已知药物.
- 新兴研究表明,酸的治疗应用范围更广.
- 了解这些扩展的用途和相关风险对于临床实践至关重要.
研究的目的:
- 审查最近关于瓦尔酸盐超出其传统适用范围的扩大功效的研究结果.
- 为了整合有关瓦尔酸盐在各种条件下有效性的信息.
- 突出不利影响和潜在的缓解策略.
主要方法:
- 对氨酸的最新研究进行了全面的文献搜索.
- 综合关于已建立和新型治疗应用的数据.
- 分析报告的不良影响和管理干预措施.
主要成果:
- 瓦尔酸对一般性和焦点性,状态和偏头痛是有效的.
- 它在治疗躁狂情绪发作或双相情感障碍方面表现出有效性,通常与一起使用.
- 该审查确定了氨酸的已知和不太知名的副作用.
结论:
- 瓦尔酸盐具有比以前认可的更广泛的治疗应用范围.
- 需要进一步的研究来探索这些扩展的用途,并解决相互矛盾的发现.
- 临床医生和研究人员需要有关氨酸的益处和风险的最新信息.
更多相关视频
09:29Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Published on: August 17, 2021
2.3K
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.0K
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
230
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
230
Antiepileptic Drugs: GABAergic Pathway Potentiators
317
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
317
Mania and Antimanic Drugs: Overview
119
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
119
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
Antiepileptic Drugs: Glutamate Antagonists
274
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
274
